Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lantronix to Participate in the 19th Annual Needham Technology, Media, & Consumer Investor Conference on May 14, 2024
-
BioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024
-
The Tile Shop Reports First Quarter 2024 Results
-
Altimmune Announces First Quarter 2024 Financial Results and Provides a Business Update
-
Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights
-
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
-
BigCommerce Announces First Quarter 2024 Financial Results
-
BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)
-
Lifetime Brands, Inc. Reports First Quarter 2024 Financial Results
-
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
-
Royalty Pharma Reports First Quarter 2024 Results
-
Advantage Solutions Reports First Quarter Results with New Reporting Segments and Reaffirms its 2024 Outlook
-
ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
PhotonPay and Discover® Global Network Connect to Launch PhotonPay Commercial Card
-
Tecnoglass Reports First Quarter 2024 Results
-
Aduro Clean Technologies Selected to Present at Chemelot Circular Hub Event in the Netherlands
-
Sterling Reports First Quarter 2024 Results
-
Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
-
Dragonfly Energy Announces Breakthrough in Lithium Battery Production: Eliminating Harmful “Forever Chemicals”
-
Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
-
Plug Announces First Quarter 2024 Financial Results
-
Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer
-
Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipeline
-
LanzaTech Announces First Quarter 2024 Financial Results and Reiterates Full Year 2024 Outlook
-
Applied Therapeutics Reports First Quarter 2024 Financial Results
-
TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors
-
First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month
-
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
-
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
-
Arqit warns CISOs why they must act now to secure their data ready for the post-quantum world
-
NOWPayments Enables Cryptocurrency Purchases of Tangem Wallets: Expanding Payment Options with BTC, ETH, USDC, and More
-
The Judge Group Launches Center of Excellence to Accelerate Virtual Model Development of Arm-based Hardware Platforms
-
Alector to Participate in Upcoming Healthcare Conferences
-
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery
-
ProQR Announces First Quarter 2024 Operating and Financial Results
-
Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results
-
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
-
Brookfield Reinsurance Announces First Quarter Results and Declares Regular Quarterly Distribution
-
Madison Metals Provides Kenora Project Update and Issues Stock Options
-
Endeavour Silver Announces Q1 2024 Financial Results; Earnings Call at 10AM PDT (1PM EDT) Today
-
Glatfelter Reports First Quarter 2024 Results
-
Titan Machinery Inc. to Report Fiscal First Quarter Ended April 30, 2024 Results on Thursday, May 23, 2024
-
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
-
Brookfield Corporation Reports Strong First Quarter Results
-
Scorpio Tankers Inc. Announces Financial Results for the First Quarter of 2024 and Declaration of a Dividend
-
Playtika Holding Corp. Reports Q1 2024 Financial Results
-
GFG Signs Binding LOI with Patriot Gold to Sell its Rattlesnake Hills Gold Project
-
Parsons To Design Advanced Rapid Transit System in San Antonio
-
Form 8.3 - Tyman plc
-
Outbrain Announces First Quarter 2024 Results

